Advertisement
Advertisement

FMS

FMS logo

Fresenius Medical Care AG

23.84
USD
Sponsored
-0.05
-0.23%
Dec 31, 15:55 UTC -5
Closed
exchange

After-Market

24.01

+0.17
+0.73%

FMS Earnings Reports

Positive Surprise Ratio

FMS beat 26 of 40 last estimates.

65%

Next Report

Date of Next Report
Feb 24, 2026
Estimate for Q4 25 (Revenue/ EPS)
$4.88B
/
$0.92
Implied change from Q3 25 (Revenue/ EPS)
-0.18%
/
-16.36%
Implied change from Q4 24 (Revenue/ EPS)
-4.10%
/
+1.10%

Fresenius Medical Care AG earnings per share and revenue

On Nov 04, 2025, FMS reported earnings of 1.10 USD per share (EPS) for Q3 25, beating the estimate of 0.96 USD, resulting in a 14.17% surprise. Revenue reached 4.88 billion, compared to an expected 4.97 billion, with a -1.72% difference. The market reacted with a -7.82% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 8 analysts forecast an EPS of 0.92 USD, with revenue projected to reach 4.88 billion USD, implying an decrease of -16.36% EPS, and decrease of -0.18% in Revenue from the last quarter.
FAQ
For Q3 2025, Fresenius Medical Care AG reported EPS of $1.10, beating estimates by 14.17%, and revenue of $4.88B, -1.72% below expectations.
The stock price moved down -7.82%, changed from $26.35 before the earnings release to $24.29 the day after.
The next earning report is scheduled for Feb 24, 2026.
Based on 8 analysts, Fresenius Medical Care AG is expected to report EPS of $0.92 and revenue of $4.88B for Q4 2025.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement